Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Effectiveness of Apidra with Basal Insulin in Diabetes
NCT00526513Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jul 2007
- Primary completion
- May 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of insulin glulisine in type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Primary endpoint: Glycosylated Haemoglobin at 6 months. Started Jul 2007; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00526513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00526513.